Syndax Pharmaceuticals CEO Briggs Morrison's 2021 pay jumps 80% to $3.9M
Syndax Pharmaceuticals reports 2021 executive compensation
By ExecPay News
Published: March 29, 2022
Syndax Pharmaceuticals reported fiscal year 2021 executive compensation information on March 29, 2022.
In 2021, four executives at Syndax Pharmaceuticals received on average a compensation package of $2.9M, a 20% increase compared to previous year.
Average pay of disclosed executives at Syndax Pharmaceuticals
Briggs W. Morrison, Chief Executive Officer, received $3.9M in total, which increased by 80% compared to 2020. 76% of Morrison's compensation, or $3M, was in option awards. Morrison also received $309K in non-equity incentive plan, $619K in salary, as well as $8K in other compensation.
Michael A. Metzger, Chief Operating Officer, received a compensation package of $3.3M, which increased by 71% compared to previous year. 73% of the compensation package, or $2.4M, was in option awards.
Daphne Karydas, Chief Financial Officer, earned $2.3M in 2021, a 27% decrease compared to previous year.
Anjali Ganguli, Chief Business Officer, received $2.1M in 2021.
Related executives
You may also like
Source: SEC filing on March 29, 2022.